Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, today announced it has secured its first ...

Ottawa, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The global mice model market size is expected to be worth over USD 19.36 billion by 2034, increasing from USD 12.12 billion in 2026, growing at a strong CAGR ...

Following peer-reviewed publication and independent expert review of findings, the LOI advances Lunai's tumor-regressing immune-cell platform toward scalable therapies for aggressive cancers ...

Researchers are shedding light on neural mechanisms underlying the progression of Alzheimer's disease. These findings will be presented at Neuroscience 2025, the annual meeting of the Society for ...

Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines". LOS ANGELES, Nov. 6, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), ...

Researchers from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine have discovered how a ...

Researchers have developed a molecule called SU212 that could revolutionize treatment for triple-negative breast cancer, one of the most aggressive and difficult-to-treat forms of the disease.

Patient-derived xenograft (PDX) models are emerging as a transformative tool in colorectal cancer (CRC) research, offering unparalleled insights into tumor biology, drug resistance, and personalized ...

The immune system plays a crucial role in fighting tumors and metastases. Consequently, it is decisive to conduct cancer ...

Malhotra says that cancer cells “need a lot of glucose” to grow and that “ENO1 plays an extremely important role providing ...